Terms: = Germ cell tumor AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
103 results:
1. Predicting immunotherapy response in melanoma using a novel tumor immunological phenotype-related gene index.
Zheng S; He A; Chen C; Gu J; Wei C; Chen Z; Liu J
Front Immunol; 2024; 15():1343425. PubMed ID: 38571962
[TBL] [Abstract] [Full Text] [Related]
2. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy.
Martinez-Morilla S; Moutafi M; Fernandez AI; Jessel S; Divakar P; Wong PF; Garcia-Milian R; Schalper KA; Kluger HM; Rimm DL
Oncoimmunology; 2023; 12(1):2260618. PubMed ID: 37781235
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
6. CD71
Bozorgmehr N; Okoye I; Mashhouri S; Lu J; Koleva P; Walker J; Elahi S
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37236637
[TBL] [Abstract] [Full Text] [Related]
7. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Goddard J; Castle J; Southworth E; Fletcher A; Crosier S; Martin-Guerrero I; García-Ariza M; Navajas A; Masliah-Planchon J; Bourdeaut F; Dufour C; Ayrault O; Goschzik T; Pietsch T; Sill M; Pfister SM; Rutkowski S; Richardson S; Hill RM; Williamson D; Bailey S; Schwalbe EC; Clifford SC; Hicks D
Acta Neuropathol; 2023 May; 145(5):651-666. PubMed ID: 37014508
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of microRNA-125a expression status in molecular groups of pediatric medulloblastoma.
Hamam SM; Abdelzaher E; Fadel SH; Nassra RA; Sharafeldin HA
Childs Nerv Syst; 2023 Jul; 39(7):1869-1880. PubMed ID: 36892621
[TBL] [Abstract] [Full Text] [Related]
9. Clinicomorphological and molecular analysis of medulloblastoma and association with survival: A single tertiary care center experience.
Badiger S; Gudipati A; Uppin M; Konatam ML; Yeramneni VK; Bhattacharjee S; Saradhi MV; Patnaik S; Irukulla M
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S592-S602. PubMed ID: 38384024
[TBL] [Abstract] [Full Text] [Related]
10. Usefulness of intraoperative rapid immunohistochemistry in the surgical treatment of brain tumors.
Inoue A; Watanabe H; Kondo T; Katayama E; Miyazaki Y; Suehiro S; Yamashita D; Taniwaki M; Kurata M; Shigekawa S; Kitazawa R; Kunieda T
Neuropathology; 2023 Jun; 43(3):209-220. PubMed ID: 36128673
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine.
Ping H; Yu W; Gong X; Tong X; Lin C; Chen Z; Cai C; Guo K; Ke H
Invest New Drugs; 2022 Dec; 40(6):1173-1184. PubMed ID: 35962880
[TBL] [Abstract] [Full Text] [Related]
12. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
[TBL] [Abstract] [Full Text] [Related]
13. Roles of the m
Yuan F; Cai X; Cong Z; Wang Y; Geng Y; Aili Y; Du C; Zhu J; Yang J; Tang C; Zhang A; Zhao S; Ma C
Front Immunol; 2022; 13():798583. PubMed ID: 35558067
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract] [Full Text] [Related]
15. ATRX-dependent SVCT2 mediates macrophage infiltration in the glioblastoma xenograft model.
Shang J; Wang Y; Li Z; Jiang L; Bai Q; Zhang X; Xiao G; Zhang J
J Neurophysiol; 2022 May; 127(5):1309-1316. PubMed ID: 35417255
[TBL] [Abstract] [Full Text] [Related]
16. Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.
Jiguet-Jiglaire C; Boissonneau S; Denicolai E; Hein V; Lasseur R; Garcia J; Romain S; Appay R; Graillon T; Mason W; Carpentier AF; Brandes AA; Ouafik L'; Wick W; Baaziz A; Gigan JP; Argüello RJ; Figarella-Branger D; Chinot O; Tabouret E
Acta Neuropathol Commun; 2022 Jan; 10(1):1. PubMed ID: 34980260
[TBL] [Abstract] [Full Text] [Related]
17. The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.
Rosager AM; Dahlrot RH; Sørensen MD; Bangsø JA; Hansen S; Kristensen BW
J Neuropathol Exp Neurol; 2022 Jan; 81(1):54-60. PubMed ID: 34875075
[TBL] [Abstract] [Full Text] [Related]
18. mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.
Conti V; Cominelli M; Pieri V; Gallotti AL; Pagano I; Zanella M; Mazzoleni S; Pivetta F; Patanè M; Scotti GM; Piras IS; Pollo B; Falini A; Zippo A; Castellano A; Maestro R; Poliani PL; Galli R
JCI Insight; 2021 Dec; 6(23):. PubMed ID: 34673573
[TBL] [Abstract] [Full Text] [Related]
19. Cerebrospinal fluid cytokine levels are associated with macrophage infiltration into tumor tissues of glioma patients.
Kemmerer CL; Schittenhelm J; Dubois E; Neumann L; Häsler LM; Lambert M; Renovanz M; Kaeser SA; Tabatabai G; Ziemann U; Naumann U; Kowarik MC
BMC Cancer; 2021 Oct; 21(1):1108. PubMed ID: 34654395
[TBL] [Abstract] [Full Text] [Related]
20. Merkel cell carcinoma presenting as a malignant pleural effusion post-COVID-19 hospitalization: A case report and literature review.
Lanceta J; Toprak M; Rosca OC
Diagn Cytopathol; 2022 Jan; 50(1):E37-E41. PubMed ID: 34609068
[TBL] [Abstract] [Full Text] [Related]
[Next]
